Optimization of Hearing Performance in the Subject Implanted
NCT ID: NCT05325450
Last Updated: 2023-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2023-05-18
2025-01-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Bilateral and Single-sided-deafness Cochlear Implants for Functioning in Complex Auditory Environments
NCT06305039
Cochlear Implantation in Single Sided Deafness and Asymmetrical Hearing Loss: a Cost/Utility Study.
NCT02204618
Optimizing Regulation of a Cochlear Implant in Patients With Functional Contralateral Audition.
NCT03202797
Peripheral and Central Influences on Auditory Temporal Processing & Speech Perception in Older Cochlear Implantees
NCT05554692
Single-sided Deafness and Cochlear Implants
NCT01749592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training A
Training A in Unilaterally postlingually-deafened adult cochlear implanted candidates
Program A
Presentation of the sentence to the implant alone
Training B
Training B in Unilaterally postlingually-deafened adult cochlear implanted candidates
Program B
Presentation of the sentence to the implanted ear, associated for the non-implanted ear
Control
Training in bilaterally postlingually-deafened adult cochlear implanted candidates
Control
Presentation of the sentences alternately to the most recently implanted ear and both implanted ears at the same time
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Program A
Presentation of the sentence to the implant alone
Program B
Presentation of the sentence to the implanted ear, associated for the non-implanted ear
Control
Presentation of the sentences alternately to the most recently implanted ear and both implanted ears at the same time
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Unilaterally postlingually-deafened adult cochlear implanted candidates (IC-Uni)
* Person with almost normal or moderate contralateral hearing ( under 60dB)
* Cochlear implanted person whose activation has not yet been performed
* Cochlear implanted subjects with bilateral post-lingual profound deafness, who already benefit from a unilateral cochlear implant and candidates to a bilateral cochlear implant
* Affiliated to social security
Exclusion Criteria
* Subjects with associated neurological or neurodegenerative conditions
* Significant anatomical changes on CT scan of the temporal bone that may interfere with the insertion of the cochlear implant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre National de la Recherche Scientifique, France
OTHER
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marx
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC31/21/0125
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.